You are currently on the new version of our website. Access the old version .

111 Results Found

  • Review
  • Open Access
31 Citations
15,999 Views
40 Pages

29 March 2021

Metabolic reactions that occur at alkylamino moieties may provide insight into the roles of these moieties when they are parts of drug molecules that act at different receptors. N-dealkylation of N,N-dialkylamino moieties has been associated with ret...

  • Article
  • Open Access
4 Citations
3,093 Views
13 Pages

Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes

  • Eleonora Colombo,
  • Stefania Olla,
  • Cristina Minnelli,
  • Alessia Formato,
  • Caterina Veroni,
  • Silvia Corbisiero,
  • Mattia Pericolo,
  • Chiara Siguri,
  • Giovanna Mobbili and
  • Pierfausto Seneci
  • + 1 author

4 October 2023

Edaravone (EDA), an antioxidant drug approved for the treatment of ischemic stroke and amyotrophic lateral sclerosis, was recently proposed as a remyelinating candidate for the treatment of multiple sclerosis. Here, we synthesized twelve EDA analogue...

  • Review
  • Open Access
28 Citations
12,857 Views
29 Pages

22 April 2020

Alkyl moieties—open chain or cyclic, linear, or branched—are common in drug molecules. The hydrophobicity of alkyl moieties in drug molecules is modified by metabolic hydroxy functionalization via free-radical intermediates to give primar...

  • Article
  • Open Access
38 Citations
16,281 Views
16 Pages

8 March 2007

While the mammalian eye is seldom considered an organ of drug metabolism, the capacity for biotransformation is present. Compared to the liver, the metabolic capabilities of the eye are minuscule; however, phase I and phase II metabolic activities ha...

  • Review
  • Open Access
55 Citations
20,664 Views
23 Pages

Cyclization-activated Prodrugs

  • Paula Gomes,
  • Nuno Vale and
  • Rui Moreira

12 November 2007

Many drugs suffer from an extensive first-pass metabolism leading to druginactivation and/or production of toxic metabolites, which makes them attractive targets forprodrug design. The classical prodrug approach, which involves enzyme-sensitive coval...

  • Article
  • Open Access
18 Citations
6,692 Views
16 Pages

10 August 2017

One of the main obstacles for cancer therapies is to deliver medicines effectively to target sites. Since stroma cells are developed around tumors, chemotherapeutic agents have to go through stroma cells in order to reach tumors. As a method to impro...

  • Article
  • Open Access
83 Citations
24,471 Views
5 Pages

14 October 2009

Many therapeutic agents are manufactured and administered in prodrug forms. In this paper, a new classification system for prodrugs is proposed to provide useful information about where in the body a prodrug is converted to the active drug. In this s...

  • Review
  • Open Access
23 Citations
8,061 Views
14 Pages

Computational Simulations to Guide Enzyme-Mediated Prodrug Activation

  • Milica Markovic,
  • Shimon Ben-Shabat and
  • Arik Dahan

Prodrugs are designed to improve pharmaceutical/biopharmaceutical characteristics, pharmacokinetic/pharmacodynamic properties, site-specificity, and more. A crucial step in successful prodrug is its activation, which releases the active parent drug,...

  • Article
  • Open Access
11 Citations
11,417 Views
26 Pages

14 May 2014

In general, prodrugs are developed to circumvent deficiencies associated with the absorption, distribution, metabolism, excretion or toxicological (ADMET) profile associated with the active drug. In our study, we select bupropion, a drug with broad p...

  • Article
  • Open Access
2 Citations
3,672 Views
25 Pages

Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different?

  • Darius Babusis,
  • Cynthia Kim,
  • Jesse Yang,
  • Xiaofeng Zhao,
  • Guoju Geng,
  • Carmen Ip,
  • Nathan Kozon,
  • Hoa Le,
  • Jennifer Leung and
  • Raju Subramanian
  • + 7 authors

10 June 2025

RNA viruses with pandemic potential pose a significant global health risk. The adenosine nucleoside analog GS-441524 is metabolized to its active GS-443902 triphosphate metabolite to inhibit a broad spectrum of RNA viruses. Intravenous (IV) remdesivi...

  • Review
  • Open Access
8 Citations
6,614 Views
23 Pages

Prodrug Therapies for Infectious and Neurodegenerative Diseases

  • Milica Markovic,
  • Suyash Deodhar,
  • Jatin Machhi,
  • Pravin Yeapuri,
  • Maamoon Saleh,
  • Benson J. Edagwa,
  • Rodney Lee Mosley and
  • Howard E. Gendelman

Prodrugs are bioreversible drug derivatives which are metabolized into a pharmacologically active drug following chemical or enzymatic modification. This approach is designed to overcome several obstacles that are faced by the parent drug in physiolo...

  • Article
  • Open Access
14 Citations
4,706 Views
14 Pages

Synthesis and Biochemical Evaluation of Baicalein Prodrugs

  • Sang-Hyun Son,
  • Jinhong Kang,
  • Myunghwan Ahn,
  • Soyeon Nam,
  • Yong Woo Jung,
  • Ki Yong Lee,
  • Young Ho Jeon,
  • Youngjoo Byun and
  • Kiho Lee

Baicalein (5,6,7-trihydroxy-2-phenyl-4H-1-benzopyran-4-one), a flavonoid analog from Scutellaria baicalensis, possesses several pharmacological activities including antioxidant, antiproliferative, and anti-inflammatory activities. We previously repor...

  • Review
  • Open Access
8 Citations
14,499 Views
23 Pages

Prodrugs in Cardiovascular Therapy

  • Marinella G. Sandros,
  • Chady B. Sarraf and
  • Maryam Tabrizian

14 May 2008

Prodrugs are biologically inactive derivatives of an active drug intended to solve certain problems of the parent drug such as toxicity, instability, minimal solubility and non-targeting capabilities. The majority of drugs for cardiovascular diseases...

  • Article
  • Open Access
8 Citations
4,885 Views
11 Pages

Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents

  • Ziad Omran,
  • Chris P. Guise,
  • Linwei Chen,
  • Cyril Rauch,
  • Ashraf N. Abdalla,
  • Omeima Abdullah,
  • Ikhlas A. Sindi,
  • Peter M. Fischer,
  • Jeff B. Smaill and
  • Qingmin Wang
  • + 2 authors

Phenanthroindolizidines, such as antofine and tylophorine, are a family of natural alkaloids isolated from different species of Asclepiadaceas. They are characterized by interesting biological activities, such as pronounced cytotoxicity against diffe...

  • Article
  • Open Access
18 Citations
9,368 Views
18 Pages

N-Monosubstituted Methoxy-oligo(ethylene glycol) Carbamate Ester Prodrugs of Resveratrol

  • Andrea Mattarei,
  • Michele Azzolini,
  • Mario Zoratti,
  • Lucia Biasutto and
  • Cristina Paradisi

3 September 2015

Resveratrol is a natural polyphenol with many interesting biological activities. Its pharmacological exploitation in vivo is, however, hindered by its rapid elimination via phase II conjugative metabolism at the intestinal and, most importantly, hepa...

  • Article
  • Open Access
10 Citations
4,151 Views
17 Pages

Compound-3 is an oral monophosphate prodrug of gemcitabine. Previous data showed that Compound-3 was more potent than gemcitabine and it was orally active in a tumor xenograft model. In the present study, the metabolism of Compound-3 was investigated...

  • Article
  • Open Access
8 Citations
3,356 Views
18 Pages

Toward Multitasking Pharmacological COX-Targeting Agents: Non-Steroidal Anti-Inflammatory Prodrugs with Antiproliferative Effects

  • Fedora Grande,
  • Francesca Giordano,
  • Maria Antonietta Occhiuzzi,
  • Carmine Rocca,
  • Giuseppina Ioele,
  • Michele De Luca,
  • Gaetano Ragno,
  • Maria Luisa Panno,
  • Bruno Rizzuti and
  • Antonio Garofalo

28 June 2021

The antitumor activity of certain anti-inflammatory drugs is often attributed to an indirect effect based on the inhibition of COX enzymes. In the case of anti-inflammatory prodrugs, this property could be attributed to the parent molecules with mech...

  • Article
  • Open Access
7 Citations
3,297 Views
23 Pages

Cold Physical Plasma-Mediated Fenretinide Prodrug Activation Confers Additive Cytotoxicity in Epithelial Cells

  • Mohsen Ahmadi,
  • Debora Singer,
  • Felix Potlitz,
  • Zahra Nasri,
  • Thomas von Woedtke,
  • Andreas Link,
  • Sander Bekeschus and
  • Kristian Wende

Cold physical plasma is a partially ionized gas operated at body temperature and utilized for heat-sensitive technical and medical purposes. Physical plasma is a multi-component system consisting of, e.g., reactive species, ions and electrons, electr...

  • Article
  • Open Access
2 Citations
11,858 Views
19 Pages

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug

  • Paul Matthew O'Byrne,
  • Robert Williams,
  • John J. Walsh and
  • John F. Gilmer

28 May 2014

N-methylbupropion was selected as a potential prodrug from our in vitro screening of analogues of bupropion described in the preceding paper. This study describes in vivo pharmacokinetics of N-methylbupropion in the guinea-pig animal model, which is...

  • Article
  • Open Access
8 Citations
3,252 Views
9 Pages

11 December 2021

Acanthamoeba species of amebae are often associated with Acanthamoeba keratitis, a severe corneal infection. Isavuconazonium sulfate is an FDA-approved drug for the treatment of invasive aspergillosis and mucormycosis. This prodrug is metabolized int...

  • Communication
  • Open Access
1 Citations
1,021 Views
9 Pages

Sugar-Linked Diethyldithiocarbamate Derivatives: A Novel Class of Anticancer Agents

  • Mohammad Najlah,
  • Niamh McCallum,
  • Ana Maria Pereira,
  • Dan Alves,
  • Niusha Ansari-Fard,
  • Sahrish Rehmani and
  • Ayşe Kaya

Disulfiram (DSF), a well-known anti-alcoholism drug, exhibits potent anticancer activity via its metabolite, diethyldithiocarbamate (DDC), which forms a cytotoxic copper complex that selectively targets cancer stem cells. However, its clinical utilit...

  • Review
  • Open Access
360 Citations
26,026 Views
20 Pages

18 February 2008

Mammalian carboxylesterases (CESs) comprise a multigene family whose geneproducts play important roles in biotransformation of ester- or amide-type prodrugs. Theyare members of an α,β-hydrolase-fold family and are found in various mammals. It has bee...

  • Feature Paper
  • Article
  • Open Access
4 Citations
4,338 Views
33 Pages

Benzotriazine Di-Oxide Prodrugs for Exploiting Hypoxia and Low Extracellular pH in Tumors

  • Michael P. Hay,
  • Hong Nam Shin,
  • Way Wua Wong,
  • Wan Wan Sahimi,
  • Aaron T.D. Vaz,
  • Pooja Yadav,
  • Robert F. Anderson,
  • Kevin O. Hicks and
  • William R. Wilson

10 July 2019

Extracellular acidification is an important feature of tumor microenvironments but has yet to be successfully exploited in cancer therapy. The reversal of the pH gradient across the plasma membrane in cells that regulate intracellular pH (pHi) has po...

  • Review
  • Open Access
1 Citations
2,502 Views
19 Pages

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, remains a major global health threat. The virus enters host cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor. Several small-molec...

  • Article
  • Open Access
12 Citations
5,200 Views
14 Pages

Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability

  • Changde Zhang,
  • Shanchun Guo,
  • Qiu Zhong,
  • Qiang Zhang,
  • Ahamed Hossain,
  • Shilong Zheng and
  • Guangdi Wang

8 December 2019

ZL277 is a prodrug of belinostat with enhanced bioavailability and efficacy as a pan histone deacetylase (HDAC) inhibitor. In this study, we investigated the metabolism and pharmacokinetics of ZL277 in liver S9 fractions, liver microsomes, liver cyto...

  • Article
  • Open Access
6 Citations
2,650 Views
21 Pages

Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands

  • Theresa Mendrina,
  • Isabella Poetsch,
  • Hemma Schueffl,
  • Dina Baier,
  • Christine Pirker,
  • Alexander Ries,
  • Bernhard K. Keppler,
  • Christian R. Kowol,
  • Dan Gibson and
  • Petra Heffeter
  • + 2 authors

For a variety of cancer types, platinum compounds are still among the best treatment options. However, their application is limited by side effects and drug resistance. Consequently, multi-targeted platinum(IV) prodrugs that target specific traits of...

  • Article
  • Open Access
10 Citations
3,606 Views
20 Pages

Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation—Relevance to Thrombosis

  • Anne Krüger-Genge,
  • Susanne Köhler,
  • Markus Laube,
  • Vanessa Haileka,
  • Sandy Lemm,
  • Karolina Majchrzak,
  • Sarah Kammerer,
  • Christian Schulz,
  • Joachim Storsberg and
  • Friedrich Jung
  • + 2 authors

29 July 2023

Cancer patients are at a very high risk of serious thrombotic events, often fatal. The causes discussed include the detachment of thrombogenic particles from tumor cells or the adverse effects of chemotherapeutic agents. Cytostatic agents can either...

  • Article
  • Open Access
6 Citations
3,681 Views
17 Pages

Influence of the Hypoxia-Activated Prodrug Evofosfamide (TH-302) on Glycolytic Metabolism of Canine Glioma: A Potential Improvement in Cancer Metabolism

  • Hiroki Yamazaki,
  • Seio Onoyama,
  • Shunichi Gotani,
  • Tatsuya Deguchi,
  • Masahiro Tamura,
  • Hiroshi Ohta,
  • Hidetomo Iwano,
  • Hidetaka Nishida,
  • Peter J. Dickinson and
  • Hideo Akiyoshi

22 November 2023

The transcription factor hypoxia-inducible factor 1α (HIF-1α) drives metabolic reprogramming in gliomas (GLs) under hypoxic conditions, promoting glycolysis for tumor development. Evofosfamide (EVO) releases a DNA-alkylating agent within...

  • Article
  • Open Access
5 Citations
3,197 Views
14 Pages

Gemcitabine (dFdC) demonstrates significant effectiveness against solid tumors in vitro and in vivo; however, its clinical application is limited because it tends to easily undergo deamination metabolism. Therefore, we synthesized 4-N-carbobenzoxy-ge...

  • Article
  • Open Access
3 Citations
2,363 Views
15 Pages

Dissecting CYP1A2 Activation by Arylalkanoic Acid Prodrugs toward the Development of Anti-Inflammatory Agents

  • Maria Antonietta Occhiuzzi,
  • Giuseppina Ioele,
  • Michele De Luca,
  • Bruno Rizzuti,
  • Domenica Scordamaglia,
  • Rosamaria Lappano,
  • Marcello Maggiolini,
  • Antonio Garofalo and
  • Fedora Grande

28 December 2023

Arylalkane-derived prodrugs of arylacetic acids are a small group of substances that have long been known for their anti-inflammatory action. Despite their ease of synthesis and good potential for the development of new potent and safe anti-inflammat...

  • Article
  • Open Access
2 Citations
1,961 Views
15 Pages

Design, Synthesis, and Antisickling Investigation of a Thiazolidine Prodrug of TD-7 That Prolongs the Duration of Action of Antisickling Aromatic Aldehyde

  • Rana T. Alhashimi,
  • Tarek A. Ahmed,
  • Lamya Alghanem,
  • Piyusha P. Pagare,
  • Boshi Huang,
  • Mohini S. Ghatge,
  • Abdelsattar M. Omar,
  • Osheiza Abdulmalik,
  • Yan Zhang and
  • Martin K. Safo

The synthetic allosteric effector of hemoglobin, TD-7 has been investigated as a potential therapeutic agent for the treatment of sickle cell disease. The pharmacologic activity of TD-7 is due to formation of a Schiff-base interaction between its ald...

  • Article
  • Open Access
4 Citations
3,577 Views
29 Pages

Hepatic carboxylesterase 1 (CES1) metabolizes numerous prodrugs into active ingredients or direct-acting drugs into inactive metabolites. We aimed to develop a semi-physiologically based pharmacokinetic (semi-PBPK) model to simultaneously predict the...

  • Article
  • Open Access
15 Citations
9,763 Views
13 Pages

Metabolism and Pharmacokinetics of the Anti-Tuberculosis Drug Ethionamide in a Flavin-Containing Monooxygenase Null Mouse

  • Amy L. Palmer,
  • Virginia L. Leykam,
  • Andrew Larkin,
  • Sharon K. Krueger,
  • Ian R. Phillips,
  • Elizabeth A. Shephard and
  • David E. Williams

25 October 2012

Multiple drug resistance (MDR) in Mycobacterium tuberculosis (mTB), the causative agent for tuberculosis (TB), has led to increased use of second-line drugs, including ethionamide (ETA). ETA is a prodrug bioactivated by mycobacterial and mammalian fl...

  • Communication
  • Open Access
7 Citations
8,130 Views
11 Pages

Efforts to take advantage of the beneficial activities of thyrotropin-releasing hormone (TRH) in the brain are hampered by its poor metabolic stability and lack of adequate central nervous system bioavailability. We report here novel and metabolicall...

  • Article
  • Open Access
3 Citations
1,643 Views
13 Pages

2 January 2025

Efficient adventitious root formation is essential in micropropagation. Auxin prodrugs, inactive precursors that convert into active auxins within the plant, offer potentially improved rooting control and reduced phytotoxicity. This study investigate...

  • Article
  • Open Access
8 Citations
3,915 Views
20 Pages

Advanced In Vivo Prediction by Introducing Biphasic Dissolution Data into PBPK Models

  • Alexander Denninger,
  • Tim Becker,
  • Ulrich Westedt and
  • Karl G. Wagner

Coupling biorelevant in vitro dissolution with in silico physiological-based pharmacokinetic (PBPK) tools represents a promising method to describe and predict the in vivo performance of drug candidates in formulation development including non-passiv...

  • Review
  • Open Access
117 Citations
20,848 Views
31 Pages

16 August 2007

The enterohepatic circulation of bile acids is one of the most efficient recycling routes in the human body. It is a complex process involving numerous transport proteins, which serve to transport bile acids from the small intestine into portal circu...

  • Feature Paper
  • Article
  • Open Access
6 Citations
3,400 Views
12 Pages

Metabolic Stability of New Mito-Protective Short-Chain Naphthoquinones

  • Zikai Feng,
  • Jason A. Smith,
  • Nuri Gueven and
  • Joselito P. Quirino

12 February 2020

Short-chain quinones (SCQs) have been identified as potential drug candidates against mitochondrial dysfunction, which is largely dependent on their reversible redox characteristics of the active quinone core. We recently synthesized a SCQ library of...

  • Brief Report
  • Open Access
31 Citations
9,440 Views
8 Pages

Remdesivir is a nucleotide prodrug that is currently undergoing extensive clinical trials for the treatment of COVID-19. The prodrug is metabolized to its active triphosphate form and interferes with the action of RNA-dependent RNA polymerase of SARS...

  • Article
  • Open Access
1 Citations
1,238 Views
16 Pages

A Novel HPLC-MS/MS Method for the Intracellular Quantification of the Active Triphosphate Metabolite of Remdesivir: GS-443902

  • Alice Palermiti,
  • Amedeo De Nicolò,
  • Miriam Antonucci,
  • Sara Soloperto,
  • Martina Billi,
  • Alessandra Manca,
  • Jessica Cusato,
  • Giorgia Menegatti,
  • Mohammed Lamorde and
  • Antonio D’Avolio
  • + 2 authors

Background: Remdesivir (RDV) is a broad-spectrum antiviral prodrug, which is rapidly metabolized in vivo within cells to the pharmacologically active triphosphate metabolite, GS-443902. On the other hand, the dephosphorylated metabolite GS-441524 is...

  • Article
  • Open Access
41 Citations
9,410 Views
18 Pages

Tributyrin Attenuates Metabolic and Inflammatory Changes Associated with Obesity through a GPR109A-Dependent Mechanism

  • Fabio Takeo Sato,
  • Yu Anne Yap,
  • Amanda Rabello Crisma,
  • Mariana Portovedo,
  • Gilson Masahiro Murata,
  • Sandro Massao Hirabara,
  • Willian Rodrigues Ribeiro,
  • Caroline Marcantonio Ferreira,
  • Maysa Mariana Cruz and
  • Marco A. R. Vinolo
  • + 9 authors

1 September 2020

Obesity is linked with altered microbial short-chain fatty acids (SCFAs), which are a signature of gut dysbiosis and inflammation. In the present study, we investigated whether tributyrin, a prodrug of the SCFA butyrate, could improve metabolic and i...

  • Review
  • Open Access
16 Citations
6,543 Views
18 Pages

Targeting Hypoxia: Revival of Old Remedies

  • Nuria Vilaplana-Lopera,
  • Maxym Besh and
  • Eui Jung Moon

29 October 2021

Tumour hypoxia is significantly correlated with patient survival and treatment outcomes. At the molecular level, hypoxia is a major driving factor for tumour progression and aggressiveness. Despite the accumulative scientific and clinical efforts to...

  • Article
  • Open Access
3 Citations
3,381 Views
11 Pages

Effects of Genetic Polymorphisms of Cathepsin A on Metabolism of Tenofovir Alafenamide

  • Soichiro Ito,
  • Takeshi Hirota,
  • Miyu Yanai,
  • Mai Muto,
  • Eri Watanabe,
  • Yuki Taya and
  • Ichiro Ieiri

20 December 2021

Cathepsin A (CatA) is important as a drug-metabolizing enzyme responsible for the activation of prodrugs, such as the anti-human immunodeficiency virus drug Tenofovir Alafenamide (TAF). The present study was undertaken to clarify the presence of poly...

  • Article
  • Open Access
5 Citations
3,342 Views
16 Pages

The antiviral remdesivir has been approved by regulatory bodies such as the European Medicines Agency (EMA) and the US Food and Drug administration (FDA) for the treatment of COVID-19. However, its efficacy is debated and toxicity concerns might limi...

  • Review
  • Open Access
35 Citations
7,880 Views
19 Pages

23 February 2022

The abnormal accumulation of methylglyoxal (MG) leading to increased glycation of protein and DNA has emerged as an important metabolic stress, dicarbonyl stress, linked to aging, and disease. Increased MG glycation produces inactivation and misfoldi...

  • Review
  • Open Access
21 Citations
4,905 Views
42 Pages

Conjugation, Prodrug, and Co-Administration Strategies in Support of Nanotechnologies to Improve the Therapeutic Efficacy of Phytochemicals in the Central Nervous System

  • Giovanna Rassu,
  • Milena Sorrenti,
  • Laura Catenacci,
  • Barbara Pavan,
  • Luca Ferraro,
  • Elisabetta Gavini,
  • Maria Cristina Bonferoni,
  • Paolo Giunchedi and
  • Alessandro Dalpiaz

Phytochemicals, produced as secondary plant metabolites, have shown interesting potential therapeutic activities against neurodegenerative diseases and cancer. Unfortunately, poor bioavailability and rapid metabolic processes compromise their therape...

  • Review
  • Open Access
1,938 Views
24 Pages

Impact of Complex Genetic and Drug–Drug Interactions on Tamoxifen Metabolism and Efficacy

  • Ibtissam Saad,
  • Kaoutar Bentayebi,
  • Soukaina Ettoury,
  • Oumaima Zarrik,
  • Ilhame Bourais,
  • Saber Boutayeb,
  • Caroline Samer,
  • Youssef Daali,
  • Rachid Eljaoudi and
  • Sara Louati

23 October 2025

Tamoxifen remains the standard treatment for hormone-sensitive breast cancer. However, significant interindividual variability in treatment response is observed. This variability may be partially explained by differences in the biotransformation of t...

  • Review
  • Open Access
230 Citations
24,826 Views
25 Pages

Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer

  • Małgorzata Wachowska,
  • Angelika Muchowicz,
  • Małgorzata Firczuk,
  • Magdalena Gabrysiak,
  • Magdalena Winiarska,
  • Małgorzata Wańczyk,
  • Kamil Bojarczuk and
  • Jakub Golab

19 May 2011

Aminolevulinic acid (ALA) is an endogenous metabolite normally formed in the mitochondria from succinyl-CoA and glycine. Conjugation of eight ALA molecules yields protoporphyrin IX (PpIX) and finally leads to formation of heme. Conversion of PpIX to...

  • Article
  • Open Access
4 Citations
2,913 Views
15 Pages

Discovery of a 2′-Fluoro,2′-Bromouridine Phosphoramidate Prodrug Exhibiting Anti-Yellow Fever Virus Activity in Culture and in Mice

  • Julia C. LeCher,
  • Keivan Zandi,
  • Vivian Vasconcelos Costa,
  • Franck Amblard,
  • Sijia Tao,
  • Dharmeshkumar Patel,
  • Sujin Lee,
  • Felipe Rocha da Silva Santos,
  • Matheus Rodrigues Goncalves and
  • Raymond F. Schinazi
  • + 10 authors

Yellow fever virus (YFV) is a potentially lethal, zoonotic, blood-borne flavivirus transmitted to humans and non-human primates by mosquitoes. Owing to multiple deadly epidemics, the WHO classifies YFV as a “high impact, high threat disease&rdq...

  • Article
  • Open Access
23 Citations
10,843 Views
18 Pages

New Water-Soluble Carbamate Ester Derivatives of Resveratrol

  • Andrea Mattarei,
  • Massimo Carraro,
  • Michele Azzolini,
  • Cristina Paradisi,
  • Mario Zoratti and
  • Lucia Biasutto

1 October 2014

Low bioavailability severely hinders exploitation of the biomedical potential of resveratrol. Extensive phase-II metabolism and poor water solubility contribute to lowering the concentrations of resveratrol in the bloodstream after oral administratio...

of 3